GLP-1

GLP-1 medications suppress appetite and accelerate fat loss, but research shows they create micronutrient deficiencies that threaten muscle,…

Evidence-based strength training protocols for semaglutide users: preserve lean muscle during weight loss with targeted resistance training and…

Medicare covers GLP-1 for diabetes but not weight loss in 2025. Learn current coverage rules, appeal strategies, and…

Research shows 50% of weight loss returns within 6 months of stopping Ozempic — but structured nutrition and…

Tirzepatide produces 10-15% greater weight loss than semaglutide in head-to-head clinical trials, but both excel when combined with…

Discover how resistance training prevents muscle loss on GLP-1 medications and creates optimal body recomposition—backed by 2024-2025 clinical…

Discover evidence-based strategies to preserve muscle while on semaglutide, including protein targets, training protocols, and micronutrient optimization based…

Recent research shows GLP-1 medications do not increase sepsis risk—and may even reduce infection complications in high-risk populations.…

GLP-1 medications lower blood glucose and suppress hepatic glucose output, creating hypoglycemia risk during intense exercise. Learn evidence-based…

GLP-1 drug costs remain a barrier to access, but recent policy changes—Medicare negotiation, international procurement reforms—are reshaping affordability…